News
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Onco-Innovations announces hepatocyte and liver microsome metabolism studies for ONC010, its lead nanoparticle-formulated PNKP inhibitor, to support future toxicology studies and regulatory submissions -
-
-
-
-
-
-
-